239122-51-1 Usage
Uses
Used in Pharmaceutical Synthesis:
5-bromo-3-fluoro-2-methoxyaniline is utilized as an intermediate in the synthesis of pharmaceuticals, leveraging its reactivity to contribute to the development of new drugs with targeted therapeutic effects.
Used in Agrochemical Production:
In the agrochemical industry, 5-bromo-3-fluoro-2-methoxyaniline serves as a key intermediate, playing a crucial role in the creation of compounds designed to protect crops and enhance agricultural productivity.
Used in Dye and Pigment Manufacturing:
5-bromo-3-fluoro-2-methoxyaniline is employed in the production of dyes and pigments, where its unique molecular structure imparts specific color characteristics and properties to the final products.
Used in Organic Chemistry Research:
Due to its stability and reactivity, 5-bromo-3-fluoro-2-methoxyaniline is a valuable compound in organic chemistry research, facilitating the exploration of new chemical reactions and the synthesis of novel organic molecules.
Used in Material Science:
In the field of material science, 5-bromo-3-fluoro-2-methoxyaniline is applied for the development of new materials with tailored properties, such as those with specific electronic, optical, or mechanical characteristics, owing to its structural features and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 239122-51-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,9,1,2 and 2 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 239122-51:
(8*2)+(7*3)+(6*9)+(5*1)+(4*2)+(3*2)+(2*5)+(1*1)=121
121 % 10 = 1
So 239122-51-1 is a valid CAS Registry Number.
239122-51-1Relevant articles and documents
IMIDAZOPYRIDAZINECARBONITRILES USEFUL AS KINASE INHIBITORS
-
Page/Page column 72-73, (2010/04/28)
The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The Formula (I) imidazopyridazines inhibit protein kinase activity thereby making them useful as anticancer agents.
Substituted benzazoles and methods of their use as inhibitors of Raf kinase
-
Page 372, (2008/06/13)
New substituted benz-azole compounds, compositions and methods of inhibition of Raf kinase activity in a human or animal subject are provided. The new compounds compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.
